Mon, September 23, 2024
Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024

Gregory Renza Reiterated (VRDN) at Buy and Held Target at $44 on, Sep 19th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-44-on-sep-19th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Gregory Renza of RBC Capital, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $44 on, Sep 19th, 2024.

Gregory has made no other calls on VRDN in the last 4 months.



There are 7 other peers that have a rating on VRDN. Out of the 7 peers that are also analyzing VRDN, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Gregory


  • Richard Law of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $31 on, Thursday, September 12th, 2024
  • Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $38 on, Wednesday, September 11th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $27 on, Tuesday, September 10th, 2024
  • Julian Harrison of "BTIG" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, September 10th, 2024
  • Leland Gershell of "Oppenheimer" Reiterated at Buy with Decreased Target to $28 on, Monday, August 12th, 2024
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $42 on, Monday, July 29th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Buy on, Tuesday, June 11th, 2024

Publication Contributing Sources